These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

544 related items for PubMed ID: 19326288

  • 1. Melatonin and melatonergic drugs on sleep: possible mechanisms of action.
    Srinivasan V, Pandi-Perumal SR, Trahkt I, Spence DW, Poeggeler B, Hardeland R, Cardinali DP.
    Int J Neurosci; 2009; 119(6):821-46. PubMed ID: 19326288
    [Abstract] [Full Text] [Related]

  • 2. Melatonergic drugs in clinical practice.
    Hardeland R, Poeggeler B, Srinivasan V, Trakht I, Pandi-Perumal SR, Cardinali DP.
    Arzneimittelforschung; 2008; 58(1):1-10. PubMed ID: 18368944
    [Abstract] [Full Text] [Related]

  • 3. Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep-wake cycle architecture.
    Descamps A, Rousset C, Millan MJ, Spedding M, Delagrange P, Cespuglio R.
    Psychopharmacology (Berl); 2009 Jul; 205(1):93-106. PubMed ID: 19370342
    [Abstract] [Full Text] [Related]

  • 4. Circadian periods of sensitivity for ramelteon on the onset of running-wheel activity and the peak of suprachiasmatic nucleus neuronal firing rhythms in C3H/HeN mice.
    Rawashdeh O, Hudson RL, Stepien I, Dubocovich ML.
    Chronobiol Int; 2011 Feb; 28(1):31-8. PubMed ID: 21182402
    [Abstract] [Full Text] [Related]

  • 5. Melatonin and synthetic melatonergic agonists: actions and metabolism in the central nervous system.
    Hardeland R, Poeggeler B.
    Cent Nerv Syst Agents Med Chem; 2012 Sep; 12(3):189-216. PubMed ID: 22640220
    [Abstract] [Full Text] [Related]

  • 6. Melatonin agonists and insomnia.
    Ferguson SA, Rajaratnam SM, Dawson D.
    Expert Rev Neurother; 2010 Feb; 10(2):305-18. PubMed ID: 20136385
    [Abstract] [Full Text] [Related]

  • 7. Pathophysiology of depression: role of sleep and the melatonergic system.
    Srinivasan V, Pandi-Perumal SR, Trakht I, Spence DW, Hardeland R, Poeggeler B, Cardinali DP.
    Psychiatry Res; 2009 Feb 28; 165(3):201-14. PubMed ID: 19181389
    [Abstract] [Full Text] [Related]

  • 8. Drug Insight: the use of melatonergic agonists for the treatment of insomnia-focus on ramelteon.
    Pandi-Perumal SR, Srinivasan V, Poeggeler B, Hardeland R, Cardinali DP.
    Nat Clin Pract Neurol; 2007 Apr 28; 3(4):221-8. PubMed ID: 17410109
    [Abstract] [Full Text] [Related]

  • 9. [Melatonin: Physiological and pharmacological aspects related to sleep: The interest of a prolonged-release formulation (Circadin®) in insomnia].
    Quera-Salva MA, Claustrat B.
    Encephale; 2018 Dec 28; 44(6):548-557. PubMed ID: 30107892
    [Abstract] [Full Text] [Related]

  • 10. Melatonin receptor agonists: new options for insomnia and depression treatment.
    Spadoni G, Bedini A, Rivara S, Mor M.
    CNS Neurosci Ther; 2011 Dec 28; 17(6):733-41. PubMed ID: 21554566
    [Abstract] [Full Text] [Related]

  • 11. Melatonin and sleep in aging population.
    Pandi-Perumal SR, Zisapel N, Srinivasan V, Cardinali DP.
    Exp Gerontol; 2005 Dec 28; 40(12):911-25. PubMed ID: 16183237
    [Abstract] [Full Text] [Related]

  • 12. Ramelteon: a review of its therapeutic potential in sleep disorders.
    Pandi-Perumal SR, Srinivasan V, Spence DW, Moscovitch A, Hardeland R, Brown GM, Cardinali DP.
    Adv Ther; 2009 Jun 28; 26(6):613-26. PubMed ID: 19568703
    [Abstract] [Full Text] [Related]

  • 13. Acute sleep-promoting action of the melatonin agonist, ramelteon, in the rat.
    Fisher SP, Davidson K, Kulla A, Sugden D.
    J Pineal Res; 2008 Sep 28; 45(2):125-32. PubMed ID: 18298466
    [Abstract] [Full Text] [Related]

  • 14. Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics?
    Srinivasan V, Brzezinski A, Pandi-Perumal SR, Spence DW, Cardinali DP, Brown GM.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun 01; 35(4):913-23. PubMed ID: 21453740
    [Abstract] [Full Text] [Related]

  • 15. Melatonin and its analogs in insomnia and depression.
    Cardinali DP, Srinivasan V, Brzezinski A, Brown GM.
    J Pineal Res; 2012 May 01; 52(4):365-75. PubMed ID: 21951153
    [Abstract] [Full Text] [Related]

  • 16. The sleep-promoting action of ramelteon (TAK-375) in freely moving cats.
    Miyamoto M, Nishikawa H, Doken Y, Hirai K, Uchikawa O, Ohkawa S.
    Sleep; 2004 Nov 01; 27(7):1319-25. PubMed ID: 15586784
    [Abstract] [Full Text] [Related]

  • 17. [Melatonin receptor agonist].
    Uchiyama M.
    Nihon Rinsho; 2015 Jun 01; 73(6):1017-22. PubMed ID: 26065135
    [Abstract] [Full Text] [Related]

  • 18. [Melatoninergic antidepressant valdoxan].
    Arushanian ÉB.
    Eksp Klin Farmakol; 2011 Jun 01; 74(7):41-5. PubMed ID: 21894769
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic potential of melatonin agonists.
    Cardinali DP, Pandi-Perumal SR, Srinivasan V, Spence DW, Trakht I.
    Expert Rev Endocrinol Metab; 2008 Mar 01; 3(2):269-279. PubMed ID: 30764095
    [Abstract] [Full Text] [Related]

  • 20. Role of the melatonin system in the control of sleep: therapeutic implications.
    Pandi-Perumal SR, Srinivasan V, Spence DW, Cardinali DP.
    CNS Drugs; 2007 Mar 01; 21(12):995-1018. PubMed ID: 18020480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.